H.C. Wainwright Reiterates Buy Rating on Autolus Therapeutics plc (AUTL)
Tweet Send to a Friend
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $9.00 price target on Autolus Therapeutics plc (NASDAQ: AUTL).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


